SU14813 double bond Z 5mg
SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3).
| Trivial name | SU14813 double bond Z 5mg |
| Catalog Number | A15250-5 |
| Alternative Name(s) | 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| Molecular Formula | C23H27FN4O4 |
| CAS# | 452105-23-6 |
| SMILES | CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O |
| Size | 5mg |
| Supplier Page | http://www.adooq.com/su14813-double-bond-z.html |